{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:38:35Z","timestamp":1707525515744},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50075","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T02:12:39Z","timestamp":1701915159000},"source":"Crossref","is-referenced-by-count":0,"title":["Improvement of Intestinal Pseudo-Obstruction by Total Parenteral Nutrition in a Young Woman With Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes: A Case Report"],"prefix":"10.7759","author":[{"given":"Naoto","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumi","family":"Satou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsune","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Maeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab AW","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015, 116:4-12. 10.1016\/j.ymgme.2015.06.004","journal-title":"Mol Genet Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000016969","article-title":"Chronic intestinal pseudo-obstruction","volume":"18","author":"Hirano I","year":"2000","unstructured":"Hirano I, Pandolfino J. Chronic intestinal pseudo-obstruction. Dig Dis. 2000, 18:83-92. 10.1159\/000016969","journal-title":"Dig Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-011-0219-8","article-title":"A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria","volume":"4","author":"Iida H","year":"2011","unstructured":"Iida H, Inamori M, Sekino Y, Sakamoto Y, Yamato S, Nakajima A. A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria. Clin J Gastroenterol. 2011, 4:141-6. 10.1007\/s12328-011-0219-8","journal-title":"Clin J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00038","article-title":"Can intestinal pseudo-obstruction drive recurrent stroke-like episodes in late-onset MELAS syndrome? A case report and review of the literature","volume":"10","author":"Gagliardi D","year":"2019","unstructured":"Gagliardi D, Mauri E, Magri F, et al.. Can intestinal pseudo-obstruction drive recurrent stroke-like episodes in late-onset MELAS syndrome? A case report and review of the literature. Front Neurol. 2019, 10:38. 10.3389\/fneur.2019.00038","journal-title":"Front Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7753","article-title":"Familial pernicious chronic intestinal pseudo-obstruction with a mitochondrial DNA A3243G mutation","volume":"56","author":"Suzuki J","year":"2017","unstructured":"Suzuki J, Iwata M, Moriyoshi H, Nishida S, Yasuda T, Ito Y. Familial pernicious chronic intestinal pseudo-obstruction with a mitochondrial DNA A3243G mutation. Intern Med. 2017, 56:1089-93. 10.2169\/internalmedicine.56.7753","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1313125","article-title":"An unusual case of paralytic ileus","volume":"50","author":"Seessle J","year":"2012","unstructured":"Seessle J, Stremmel W, Ebinger F, Merle U. An unusual case of paralytic ileus. Z Gastroenterol. 2012, 50:1161-5. 10.1055\/s-0032-1313125","journal-title":"Z Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24736","article-title":"Pseudo-obstruction, stroke, and mitochondrial dysfunction: a lethal combination","volume":"80","author":"Ng YS","year":"2016","unstructured":"Ng YS, Feeney C, Schaefer AM, et al.. Pseudo-obstruction, stroke, and mitochondrial dysfunction: a lethal combination. Ann Neurol. 2016, 80:686-92. 10.1002\/ana.24736","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano M","year":"1992","unstructured":"Hirano M, Ricci E, Koenigsberger MR, et al.. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord. 1992, 2:125-35. 10.1016\/0960-8966(92)90045-8","journal-title":"Neuromuscul Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga S","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, et al.. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012, 1820:619-24. 10.1016\/j.bbagen.2011.03.015","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-317964","article-title":"Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa Y","year":"2019","unstructured":"Ohsawa Y, Hagiwara H, Nishimatsu SI, et al.. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019, 90:529-36. 10.1136\/jnnp-2018-317964","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.02.024","article-title":"Incretin-based drugs and intestinal obstruction: a pharmacovigilance study","volume":"75","author":"Gudin B","year":"2020","unstructured":"Gudin B, Ladhari C, Robin P, Laroche ML, Babai S, Hillaire-Buys D, Faillie JL. Incretin-based drugs and intestinal obstruction: a pharmacovigilance study. Therapie. 2020, 75:641-7. 10.1016\/j.therap.2020.02.024","journal-title":"Therapie"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001694","article-title":"[A case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) complicated by chronic intestinal pseudo-obstruction]","volume":"62","author":"Miyanaga R","year":"2022","unstructured":"Miyanaga R, Tanaka M, Nonaka T, Shizukawa H, Shimohama S. [A case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) complicated by chronic intestinal pseudo-obstruction]. Rinsho Shinkeigaku. 2022, 62:464-8. 10.5692\/clinicalneurol.cn-001694","journal-title":"Rinsho Shinkeigaku"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2009.01838.x","article-title":"The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine","volume":"12","author":"O'Dea CJ","year":"2010","unstructured":"O'Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010, 12:540-8. 10.1111\/j.1463-1318.2009.01838.x","journal-title":"Colorectal Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000458","article-title":"Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride","volume":"82","author":"Primiano G","year":"2014","unstructured":"Primiano G, Plantone D, Forte F, Sauchelli D, Scaldaferri F, Gasbarrini A, Servidei S. Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride. Neurology. 2014, 82:1932-4. 10.1212\/WNL.0000000000000458","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42262-2","article-title":"Quantitative variation in m.3243a > G mutation produce discrete changes in energy metabolism","volume":"9","author":"McMillan RP","year":"2019","unstructured":"McMillan RP, Stewart S, Budnick JA, Caswell CC, Hulver MW, Mukherjee K, Srivastava S. Quantitative variation in m.3243a > G mutation produce discrete changes in energy metabolism. Sci Rep. 2019, 9:5752. 10.1038\/s41598-019-42262-2","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.4.855","article-title":"Age and cause of death in mitochondrial diseases","volume":"53","author":"Klopstock T","year":"1999","unstructured":"Klopstock T, Jaksch M, Gasser T. Age and cause of death in mitochondrial diseases. Neurology. 1999, 53:855-7. 10.1212\/wnl.53.4.855","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.03.054","article-title":"Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction","volume":"137","author":"Amiot A","year":"2009","unstructured":"Amiot A, Tchikviladz\u00e9 M, Joly F, et al.. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology. 2009, 137:101-9. 10.1053\/j.gastro.2009.03.054","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i33.4557","article-title":"Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases","volume":"18","author":"Sekino Y","year":"2012","unstructured":"Sekino Y, Inamori M, Yamada E, et al.. Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases. World J Gastroenterol. 2012, 18:4557-62. 10.3748\/wjg.v18.i33.4557","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12191","article-title":"Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases","volume":"25","author":"Sabbagh C","year":"2013","unstructured":"Sabbagh C, Amiot A, Maggiori L, Corcos O, Joly F, Panis Y. Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases. Neurogastroenterol Motil. 2013, 25:e680-6. 10.1111\/nmo.12191","journal-title":"Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.03.143","article-title":"GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic \u03b2 cells","volume":"447","author":"Ogata M","year":"2014","unstructured":"Ogata M, Iwasaki N, Ide R, Takizawa M, Uchigata Y. GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic \u03b2 cells. Biochem Biophys Res Commun. 2014, 447:133-8. 10.1016\/j.bbrc.2014.03.143","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/279530","article-title":"Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function","volume":"2011","author":"Marathe CS","year":"2011","unstructured":"Marathe CS, Rayner CK, Jones KL, Horowitz M. Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function. Exp Diabetes Res. 2011, 2011:279530. 10.1155\/2011\/279530","journal-title":"Exp Diabetes Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2430","article-title":"Incretin-based drugs and risk of intestinal obstruction among patients with type 2 diabetes","volume":"111","author":"Faillie JL","year":"2022","unstructured":"Faillie JL, Yin H, Yu OH, Herrero A, Altwegg R, Renoux C, Azoulay L. Incretin-based drugs and risk of intestinal obstruction among patients with type 2 diabetes. Clin Pharmacol Ther. 2022, 111:272-82. 10.1002\/cpt.2430","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196522-improvement-of-intestinal-pseudo-obstruction-by-total-parenteral-nutrition-in-a-young-woman-with-mitochondrial-myopathy-encephalopathy-lactic-acidosis-and-stroke-like-episodes-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:30Z","timestamp":1707509370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196522-improvement-of-intestinal-pseudo-obstruction-by-total-parenteral-nutrition-in-a-young-woman-with-mitochondrial-myopathy-encephalopathy-lactic-acidosis-and-stroke-like-episodes-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.50075","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}